During the past decade, Maryland Digestive Disease Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maryland Digestive Disease Research" #1 sponsor was "Bausch Health Americas, Inc." with 3 trials, followed by "Braintree Laboratories" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "GlobeImmune" with 1 trials sponsored and "Synta Pharmaceuticals Corp." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Maryland Digestive Disease Research" are "Crohn's Disease" (2 trials), "Chronic Hepatitis C" (1 trials), "Chronic Hepatitis C Virus Genotype 1" (1 trials), "Colon Cancer" (1 trials) and "Colonoscopy" (1 trials). Many other conditions were trialed in "Maryland Digestive Disease Research" in a lesser frequency.

Most popular intervention types in "Maryland Digestive Disease Research" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Ribavirin" (2 trials), "Viramidine" (2 trials), "BLI850" (1 trials), "BMS-824393" (1 trials) and "GI-5005" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maryland Digestive Disease Research" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maryland Digestive Disease Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Maryland Digestive Disease Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Maryland Digestive Disease Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".